Preclinical wound-healing studies with recombinant human basic fibroblast growth factor.
Fiddes
J C
JC
California Biotechnology, Inc., Mountain View 94043.
Hebda
P A
PA
Hayward
P
P
Robson
M C
MC
Abraham
J A
JA
Klingbeil
C K
CK
D000287:Administration, Topical; D000818:Animals; D001424:Bacterial Infections / Q000473:pathology; D003921:Diabetes Mellitus, Experimental / Q000473:pathology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D006099:Granuloma / Q000473:pathology; D051379:Mice; D008817:Mice, Mutant Strains; D051381:Rats; D011994:Recombinant Proteins / Q000494:pharmacology; D012867:Skin / Q000473:pathology; D013552:Swine; D013630:Tampons, Surgical; D014945:Wound Healing
D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2